| 鸿伟亚洲 |
金子博 |
减持 |
-130361489 |
686.11万股 |
0.14% |
好仓 |
2022-01-13 |
| 鸿伟亚洲 |
City East Investments Limited |
减持 |
-130361489 |
686.11万股 |
0.14% |
好仓 |
2022-01-13 |
| 鸿伟亚洲 |
Mutual Benefits Enterprise Limited |
减持 |
-130361489 |
686.11万股 |
0.14% |
好仓 |
2022-01-13 |
| 凯莱英 |
Morgan Stanley |
减持 |
-206163 |
123.87万股 |
0.06% |
好仓 |
2022-01-13 |
| 融创中国 |
Morgan Stanley |
增持 |
468905384 |
54026.14万股 |
0.11% |
好仓 |
2022-01-13 |
| 三生制药 |
CPEChina Fund, L.P. |
减持 |
-126117775 |
34609.46万股 |
0.14% |
好仓 |
2022-01-13 |
| 三生制药 |
CS Sunshine Investment Limited |
减持 |
-126117775 |
34609.46万股 |
0.14% |
好仓 |
2022-01-13 |
| 三生制药 |
Citron PE Holdings Limited |
减持 |
-126117775 |
34609.46万股 |
0.14% |
好仓 |
2022-01-13 |
| 三生制药 |
Citron PE Associates, L.P. |
减持 |
-126117775 |
34609.46万股 |
0.14% |
好仓 |
2022-01-13 |
| 三生制药 |
Citron PE Funds Limited |
减持 |
-126117775 |
34609.46万股 |
0.14% |
好仓 |
2022-01-13 |
| 腾盛博药-B |
沈南鹏 |
减持 |
-13660908 |
4486.21万股 |
0.06% |
好仓 |
2022-01-13 |
| 腾盛博药-B |
SNP China Enterprises Limited |
减持 |
-14630753 |
4389.23万股 |
0.06% |
好仓 |
2022-01-13 |
| 腾盛博药-B |
SC China Holding Limited |
减持 |
-14630753 |
4389.23万股 |
0.06% |
好仓 |
2022-01-13 |
| 首都金融控股 |
张伟 |
增持 |
13460000 |
9971.79万股 |
0.10% |
好仓 |
2022-01-13 |
| 三生制药 |
CITIC Securities Company Limited |
减持 |
-126117775 |
34649.46万股 |
0.14% |
好仓 |
2022-01-13 |
| 博华太平洋 |
董济铭 |
增持 |
3000000000 |
300000.00万股 |
0.42% |
好仓 |
2022-01-13 |
| 九兴控股 |
Cordwalner Bonaventure Inc. |
减持 |
-88603621 |
17350.86万股 |
0.22% |
好仓 |
2022-01-12 |
| 弘浩国际控股 |
温浩然 |
减持 |
-480000000 |
12000.00万股 |
0.62% |
好仓 |
2022-01-12 |
| 弘浩国际控股 |
Vertical Technology Investment Limited |
减持 |
-480000000 |
12000.00万股 |
0.62% |
好仓 |
2022-01-12 |
| 弘浩国际控股 |
辛冠群 |
减持 |
-480000000 |
12000.00万股 |
0.62% |
好仓 |
2022-01-12 |
